Search Results - "Griñan, Tania"
-
1
Sticholysin II-mediated cytotoxicity involves the activation of regulated intracellular responses that anticipates cell death
Published in Biochimie (01-05-2018)“…Sticholysin II (StII) is a pore-forming toxin of biomedical interest that belongs to the actinoporin protein family. Sticholysins are currently under…”
Get full text
Journal Article -
2
Anti-NeuGcGM3 reactivity: a possible role of natural antibodies and B-1 cells in tumor immunosurveillance
Published in Annals of the New York Academy of Sciences (01-12-2015)“…While not naturally expressed in normal human tissues, N‐glycolylated (NeuGc) gangliosides are overexpressed in several tumors and have immunosuppressive…”
Get full text
Journal Article -
3
Characterization of the Antibody Response against NeuGcGM3 Ganglioside Elicited in Non-Small Cell Lung Cancer Patients Immunized with an Anti-Idiotype Antibody
Published in The Journal of immunology (1950) (01-11-2008)“…1E10 mAb is an anti-Id murine mAb (Ab2 mAb) specific for an Ab1 mAb that reacts with NeuGc-containing gangliosides, sulfatides, and Ags expressed in some human…”
Get full text
Journal Article -
4
Dose-Dependent Induction of an Idiotypic Cascade by Anti-Glycosaminoglycan Monoclonal Antibody in apoE -/- Mice: Association with Atheroprotection
Published in Frontiers in immunology (03-03-2017)“…Atherosclerosis, the underlying pathology of most cardiovascular diseases, is triggered by the retention of apolipoprotein B (apoB)-containing lipoproteins in…”
Get full text
Journal Article -
5
Arresting progressive atherosclerosis by immunization with an anti-glycosaminoglycan monoclonal antibody in apolipoprotein E-deficient mice
Published in Free radical biology & medicine (01-12-2015)“…Atherogenesis is associated with the early retention of low-density lipoproteins (LDL) in the arterial intima by interaction with glycosaminoglycan (GAG)-side…”
Get full text
Journal Article -
6
Human antibodies reactive to NeuGcGM3 ganglioside have cytotoxic antitumor properties
Published in European journal of immunology (01-03-2013)“…N‐glycolylated gangliosides are not naturally expressed in healthy human tissues but are overexpressed in several tumors. We demonstrate the existence of…”
Get full text
Journal Article -
7
Anti-NeuGcGM3 antibodies, actively elicited by idiotypic vaccination in nonsmall cell lung cancer patients, induce tumor cell death by an oncosis-like mechanism
Published in The Journal of immunology (1950) (15-03-2011)“…1E10 is a murine anti-idiotypic mAb specific for an idiotypic mAb that reacts with NeuGc-containing gangliosides, sulfatides, and Ags expressed in some human…”
Get full text
Journal Article -
8
Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibody
Published in mAbs (01-09-2014)“…The progression of atherosclerosis is favored by increasing amounts of chondroitin sulfate proteoglycans in the artery wall. We previously reported the…”
Get full text
Journal Article -
9
Antiatherosclerotic Effect of an Antibody That Binds to Extracellular Matrix Glycosaminoglycans
Published in Arteriosclerosis, thrombosis, and vascular biology (01-03-2012)“…OBJECTIVE—Subendothelial retention of proatherogenic lipoproteins by proteoglycans is critical in atherosclerosis. The aim of this study was to characterize…”
Get full text
Journal Article -
10
Human antibodies reactive to N eu G c GM 3 ganglioside have cytotoxic antitumor properties
Published in European journal of immunology (01-03-2013)“…N ‐ glycolylated gangliosides are not naturally expressed in healthy human tissues but are overexpressed in several tumors. We demonstrate the existence of…”
Get full text
Journal Article -
11
Switching on cytotoxicity by a single mutation at the heavy chain variable region of an anti-ganglioside antibody
Published in Molecular immunology (01-04-2011)“…Gangliosides are sialic acid-containing glycosphingolipids present in the plasma membrane of most mammalian cells. In humans, the expression of the…”
Get full text
Journal Article -
12
-
13
Abstract 466: Therapeutic Immunization with an Antiglycosaminoglycan Antibody Reduces Atherosclerotic Lesion Progression in Apolipoprotein E-Deficient Mice
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2016)“…Abstract only Subendothelial retention of apoB-containing lipoproteins by interaction with glycosaminoglycan-side chains of proteoglycans is considered the key…”
Get full text
Journal Article -
14
Natural cytotoxic anti-tumor antibodies against NeuGcGM3 in healthy donors (127.4)
Published in The Journal of immunology (1950) (01-05-2012)“…N-glycolylated (NeuGc) gangliosides are not naturally expressed in normal human tissues but are overexpressed in several tumors and have immunosuppressive…”
Get full text
Journal Article -
15
P3 mAb: An Immunogenic Anti-NeuGcGM3 Antibody with Unusual Immunoregulatory Properties
Published in Frontiers in immunology (2012)“…P3 is a murine IgM mAb that recognize N-glycosylated gangliosides, sulfatides, and antigens expressed in melanoma, breast, and lung human tumors. This antibody…”
Get full text
Journal Article -
16
B cells and CD8+ T cells interaction during the establishment of an anti-idiotypic response against the syngeneic monoclonal antibody P3
Published in Biotecnología Aplicada (01-06-2018)Get full text
Journal Article -
17
Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibody
Published in mAbs (03-09-2014)“…The progression of atherosclerosis is favored by increasing amounts of chondroitin sulfate proteoglycans in the artery wall. We previously reported the…”
Get full text
Report